S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
15 A.I. Trading Opportunities a Day (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
With oil prices slumping, OPEC+ producers weigh more production cuts
15 A.I. Trading Opportunities a Day (Ad)
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Apple is expected to unveil a sleek, pricey headset. Is it the device VR has been looking for?
15 A.I. Trading Opportunities a Day (Ad)
Chuck Todd leaving NBC political panel show 'Meet the Press' and being replaced by Kristen Welker
Chuck Todd says he's leaving 'Meet the Press' after a tumultuous near-decade moderating the NBC political panel show
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
15 A.I. Trading Opportunities a Day (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
With oil prices slumping, OPEC+ producers weigh more production cuts
15 A.I. Trading Opportunities a Day (Ad)
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Apple is expected to unveil a sleek, pricey headset. Is it the device VR has been looking for?
15 A.I. Trading Opportunities a Day (Ad)
Chuck Todd leaving NBC political panel show 'Meet the Press' and being replaced by Kristen Welker
Chuck Todd says he's leaving 'Meet the Press' after a tumultuous near-decade moderating the NBC political panel show
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
15 A.I. Trading Opportunities a Day (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
With oil prices slumping, OPEC+ producers weigh more production cuts
15 A.I. Trading Opportunities a Day (Ad)
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Apple is expected to unveil a sleek, pricey headset. Is it the device VR has been looking for?
15 A.I. Trading Opportunities a Day (Ad)
Chuck Todd leaving NBC political panel show 'Meet the Press' and being replaced by Kristen Welker
Chuck Todd says he's leaving 'Meet the Press' after a tumultuous near-decade moderating the NBC political panel show
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
15 A.I. Trading Opportunities a Day (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
With oil prices slumping, OPEC+ producers weigh more production cuts
15 A.I. Trading Opportunities a Day (Ad)
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Apple is expected to unveil a sleek, pricey headset. Is it the device VR has been looking for?
15 A.I. Trading Opportunities a Day (Ad)
Chuck Todd leaving NBC political panel show 'Meet the Press' and being replaced by Kristen Welker
Chuck Todd says he's leaving 'Meet the Press' after a tumultuous near-decade moderating the NBC political panel show
NASDAQ:NVNO

enVVeno Medical (NVNO) Stock Forecast, Price & News

$3.16
+0.19 (+6.40%)
(As of 06/2/2023 ET)
Compare
Today's Range
$2.87
$3.17
50-Day Range
$2.91
$5.19
52-Week Range
$2.83
$7.93
Volume
45,519 shs
Average Volume
51,673 shs
Market Capitalization
$29.93 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

NVNO stock logo

About enVVeno Medical (NASDAQ:NVNO) Stock

enVVeno Medical Corporation (Nasdaq: NVNO) is an medical device company focused on the development of innovative bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. The company’s lead product, the VenoValve®️, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI). Deep venous CVI occurs when valves inside of the deep veins of the leg become damaged, resulting in insufficient blood being returned to the heart. The malfunctioning vein valves cause blood to flow backwards (reflux) and pool in the lower leg, increasing the pressure within the veins of the leg (venous hypertension). In the most severe cases, CVI can lead to venous ulcers (open skin sores) that become chronic and difficult to heal. The VenoValve is implanted in the femoral vein and works as a replacement venous valve, designed to reduce reflux and venous hypertension, and to restore proper directional blood flow back to the heart. With severe deep venous CVI impacting an estimated 2.4 million people in the U.S., who have no effective treatment options, the VenoValve has received Breakthrough Device Designation from the U.S. Food and Drug Administration, and is currently being evaluated in the SAVVE U.S. clinical trial.

Receive NVNO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for enVVeno Medical and its competitors with MarketBeat's FREE daily newsletter.

NVNO Stock News Headlines

66,000% upside on tiny biotech?
The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.
enVVeno Medical (NASDAQ:NVNO) Trading Down 3.5%
Sell Every Stock, Except ONE (Ticker Revealed)
We saw one of the longest bull markets in history, with the S&P surging well over 800% But now the chickens have come home to roost. However, Jeff Clark couldn’t care less because he ignores almost every single stock in the market.
NVNO enVVeno Medical Corporation
See More Headlines

NVNO Price History

NVNO Company Calendar

Last Earnings
8/11/2021
Today
6/04/2023
Next Earnings (Estimated)
8/02/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:NVNO
Employees
19
Year Founded
N/A

Profitability

Net Income
$-24,670,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$3.60 per share

Miscellaneous

Free Float
7,928,000
Market Cap
$29.93 million
Optionable
Not Optionable
Beta
1.24

Key Executives

  • Robert Andrew BermanRobert Andrew Berman
    Chief Executive Officer & Director
  • Craig T. Glynn
    Chief Financial Officer & Treasurer
  • Marc H. GlickmanMarc H. Glickman
    Chief Medical Officer & Senior Vice President
  • Hamed Alavi
    Vice President-Research, Development & Quality













NVNO Stock - Frequently Asked Questions

How have NVNO shares performed in 2023?

enVVeno Medical's stock was trading at $5.10 at the beginning of 2023. Since then, NVNO stock has decreased by 38.0% and is now trading at $3.16.
View the best growth stocks for 2023 here
.

When is enVVeno Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 2nd 2023.
View our NVNO earnings forecast
.

How were enVVeno Medical's earnings last quarter?

enVVeno Medical Corporation (NASDAQ:NVNO) released its earnings results on Wednesday, August, 11th. The company reported ($0.28) earnings per share for the quarter, beating the consensus estimate of ($0.34) by $0.06.

What is enVVeno Medical's stock symbol?

enVVeno Medical trades on the NASDAQ under the ticker symbol "NVNO."

Who are enVVeno Medical's major shareholders?

enVVeno Medical's stock is owned by many different institutional and retail investors. Top institutional shareholders include Susquehanna International Group LLP (0.46%) and Dimensional Fund Advisors LP (0.25%). Insiders that own company stock include Francis Duhay, Gmt Capital Corp, Holding SA Biodyne, Marc H Glickman, Matthew Jenusaitis, Robert Andrew Berman, Robert Gray and Sanjay Shrivastava.
View institutional ownership trends
.

How do I buy shares of enVVeno Medical?

Shares of NVNO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is enVVeno Medical's stock price today?

One share of NVNO stock can currently be purchased for approximately $3.16.

How much money does enVVeno Medical make?

enVVeno Medical (NASDAQ:NVNO) has a market capitalization of $29.93 million.

How can I contact enVVeno Medical?

enVVeno Medical's mailing address is 70 DOPPLER, IRVINE CA, 92618. The official website for the company is www.hancockjaffe.com. The company can be reached via phone at (949) 261-2900 or via fax at 949-261-2992.

This page (NASDAQ:NVNO) was last updated on 6/4/2023 by MarketBeat.com Staff

My Account -